J&J Lawsuit Claims Wyeth’s Effexor XR Infringes Patent
This article was originally published in The Pink Sheet Daily
Executive Summary
Johnson & Johnson subsidiary Alza files patent infringement suit against Wyeth.
You may also be interested in...
Teva’s Effexor Generic Launches Following ANDA Approval
Teva began shipping the generic of Wyeth's antidepressant Aug. 4.
Wyeth Plans To Launch Lybrel, DVS-233 In 2007 After Resolving Manufacturing Issues
Manufacturing facility concerns likely will derail approval of the oral contraceptive and the antidepressant before the end of the year.
With Winrevair Approved, Merck Has A Chance To Execute On CV Strategy
The activin signaling inhibitor sotatercept was approved by the US FDA for pulmonary arterial hypertension.